Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11944658 Methods of heat inactivation of adenovirus

Patent 11944658 was granted and assigned to Ultragenyx Pharmaceutical on April, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical
0
Date Filed
April 23, 2021
0
Date of Patent
April 2, 2024
0
Patent Applicant
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical
0
Patent Application Number
17238743
0
Patent Citations
‌
US Patent 8409842 Recombinant adeno-associated virus production
0
‌
US Patent 8980247 Parvovirus methods and compositions for killing neoplastic cells
0
‌
US Patent 8512981 Vectors with modified initiation codon for the translation of AAV-Rep78 useful for production of AAV
0
‌
US Patent 6846665 Method of producing a recombinant adeno-associated virus, suitable means for producing the same and use thereof for producing a medicament
0
‌
US Patent 6943019 Methods and vector constructs useful for production of recombinant AAV
0
‌
US Patent 7271002 Production of adeno-associated virus in insect cells
0
‌
US Patent 7510872 Recombinant adeno-associated virus production
0
‌
US Patent 8163543 AAV vectors produced in insect cells
0
Patent Inventor Names
Christopher J. Morrison
0
James D. Maratt
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11944658
0
Patent Primary Examiner
‌
Robert M Kelly
0

Find more entities like US Patent 11944658 Methods of heat inactivation of adenovirus

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.